» Articles » PMID: 35894797

Risk Factors for Early Adverse Outcomes After Bovine Jugular Vein Conduit Implantation: Influence of Oversized Conduit on the Outcomes

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: We investigated potential risk factors for early failure of bovine jugular vein conduit (Contegra®) implantation for right ventricular outflow tract (RVOT) reconstruction.

Methods: A single-centre retrospective review of 115 consecutive patients (54 males) who underwent RVOT reconstruction with Contegra between 2016 and 2019 was performed. Overall survival, explantation-free survival and freedom from significant RVOT lesions (valve regurgitation ≥ moderate or flow velocity ≥3.5 m/s) were investigated.

Results: Median age, body weight and Contegra diameter were 10.3 months [interquartile range (IQR) 5.7-26.9 months], 7.8 kg (IQR 6.3-12.4 kg) and 14 mm (IQR 12-16 mm), respectively. During the median follow-up duration of 25.1 months, there were 7 deaths, 34 significant RVOT lesions, 10 endocarditis episodes and 15 explantations. Overall survival and explantation-free survival at 3 years were 94.8% and 78.4%, respectively. Significant RVOT lesions (n = 34) comprised 20 stenoses, 8 regurgitations and 6 combined lesions. Freedom from significant RVOT lesions at 3 years was 62.6%. Cox regression identified higher indexed Contegra size (Contegra diameter/body weight, mm/kg) as the only risk factor for decreased time to explantation or death (hazard ratio 2.32, P < 0.001) and time to significant RVOT lesions development (hazard ratio 2.75, P < 0.001). The cut-off value of indexed Contegra size for significant RVOT lesions at 12 months was 1.905 mm/kg (sensitivity, 0.75; specificity, 0.78; area under the curve, 0.82).

Conclusions: Outcomes of RVOT reconstruction using Contegra were acceptable. However, oversized Contegra should be avoided when possible.

Irb Approval Date: 26 October 2020.

Irb Registration Number: S2020-2505-0001.

Citing Articles

Outcomes after Biventricular Repair Using a Conduit between the Right Ventricle and Pulmonary Artery in Infancy.

Jang D, Kim D, Choi E, Yun T, Park C J Chest Surg. 2024; 57(1):70-78.

PMID: 38174893 PMC: 10792375. DOI: 10.5090/jcs.23.107.


Medium-term outcomes of bovine jugular valved conduits for right ventricular outflow tract reconstruction in children: a retrospective cohort study from China.

Hao S, Zou M, Cao F, Chen W, Liu J, Ma L Transl Pediatr. 2023; 12(10):1842-1852.

PMID: 37969123 PMC: 10644029. DOI: 10.21037/tp-23-287.


Past, present, and future options for right ventricular outflow tract reconstruction.

Carrel T Front Surg. 2023; 10:1185324.

PMID: 37334202 PMC: 10272445. DOI: 10.3389/fsurg.2023.1185324.

References
1.
Boethig D, Thies W, Hecker H, Breymann T . Mid term course after pediatric right ventricular outflow tract reconstruction: a comparison of homografts, porcine xenografts and Contegras. Eur J Cardiothorac Surg. 2004; 27(1):58-66. DOI: 10.1016/j.ejcts.2004.09.009. View

2.
Breymann T, Boethig D, Goerg R, Thies W . The Contegra bovine valved jugular vein conduit for pediatric RVOT reconstruction: 4 years experience with 108 patients. J Card Surg. 2004; 19(5):426-31. DOI: 10.1111/j.0886-0440.2004.04083.x. View

3.
Van Dijck I, Budts W, Cools B, Eyskens B, Boshoff D, Heying R . Infective endocarditis of a transcatheter pulmonary valve in comparison with surgical implants. Heart. 2014; 101(10):788-93. DOI: 10.1136/heartjnl-2014-306761. View

4.
Pettersen M, Du W, Skeens M, Humes R . Regression equations for calculation of z scores of cardiac structures in a large cohort of healthy infants, children, and adolescents: an echocardiographic study. J Am Soc Echocardiogr. 2008; 21(8):922-34. DOI: 10.1016/j.echo.2008.02.006. View

5.
Morales D, Braud B, Gunter K, Carberry K, Arrington K, Heinle J . Encouraging results for the Contegra conduit in the problematic right ventricle-to-pulmonary artery connection. J Thorac Cardiovasc Surg. 2006; 132(3):665-71. DOI: 10.1016/j.jtcvs.2006.03.061. View